<DOC>
	<DOC>NCT00681590</DOC>
	<brief_summary>This study will evaluate the safety over 6 months of two different doses of vitamin D (cholecalciferol) in men and women age 65 and older. It will also evaluate if supplementation with vitamin D improves physical performance.</brief_summary>
	<brief_title>Safety of Vitamin D Supplementation in Older Persons</brief_title>
	<detailed_description>120 ambulatory men and women ages 65 to 95 will be enrolled in this study. Each subject will participate in the clinical trial for 6 months. Parathyroid hormone, vitamin D, and serum and urinary calcium will be measured periodically. Physical performance will be tested at baseline and throughout the study.</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>ambulatory hypercalcemia hypercalciuria &gt; 4 mg/kg body weight/day primary, secondary, or tertiary hyperparathyroidism renal insufficiency (serum creatinine &gt; 2 mg/dL ) history of nephrolithiasis treatment with vitamin D (ergocalciferol, cholecalciferol, calcitriol) treatment with anticonvulsants Paget's disease severe cardiac, pulmonary, hepatic, renal, or neurological disease life expectancy &lt; 1 year participation in another trial</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>deficiency</keyword>
	<keyword>elderly</keyword>
</DOC>